StockData
MIRA Pharmaceuticals, Inc. logo

MIRA Pharmaceuticals, Inc. (MIRA) stock

MIRANasdaqPharmaceutical Preparations
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026Score 7/30
$0.29−0.08 (-20.99%)

Close on Nov 20, 2026Market cap $12.23MP/E –Yield –

MIRA Pharmaceuticals cash

Cash and short-term investments held at the end of each period.

MIRA Pharmaceuticals's cash was $8.11M at Jun 30, 2026. For fiscal 2025 it was $11.03M, up 289.4% from the year before.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$11.03M+289.4%
FY2024Dec 31, 2024$2.83M-38.4%
FY2023Dec 31, 2023$4.60M+1211.4%
FY2022Dec 31, 2022$350.98K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$8.11M+1010.7%
Q1 FY2026Mar 31, 2026$4.67M+287.3%
Q4 FY2025Dec 31, 2025$11.03M+289.4%
Q3 FY2025Sep 30, 2025$7.54M+81.8%
Q2 FY2025Jun 30, 2025$730.48K-74.1%
Q1 FY2025Mar 31, 2025$1.21M-65.8%
Q4 FY2024Dec 31, 2024$2.83M-38.4%
Q3 FY2024Sep 30, 2024$4.14M-29.4%
Q2 FY2024Jun 30, 2024$2.82M+11275.7%
Q1 FY2024Mar 31, 2024$3.53M+905.4%
Q4 FY2023Dec 31, 2023$4.60M–
Q3 FY2023Sep 30, 2023$5.87M–
Q2 FY2023Jun 30, 2023$24.82K–
Q4 FY2022Dec 31, 2022$350.98K–

More MIRA Pharmaceuticals figures

See a number that looks wrong?